Michael McKee, MD, MPH, Ben Case, Maureen Fausone, Philip Zazove, MD, MM, Alicia Ouellette, JD, and Michael D. Fetters, MD, MPH, MA
For reasons of medical ethics, medical schools should embrace functional technical standards that focus on the capabilities of students with disabilities.
AMA J Ethics. 2016;18(10):993-1002. doi:
10.1001/journalofethics.2016.18.10.medu1-1610.
This month, AMA Journal of Ethics theme editor Margaret Cocks, MD, PhD, a third-year resident at Johns Hopkins Hospital, interviewed Theonia Boyd, MD, about ethical issues pathologists face when conducting autopsies and obtaining specimens.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
The pace at which neurotechnological developments are being translated into clinical applications calls for a preparatory neuroethical model that can plot the benefits, burdens, and risks of neurosurgery as a step toward minimizing risks and maximizing benefits.